STOCK TITAN

Clover Health Investments, Corp - CLOV STOCK NEWS

Welcome to our dedicated page for Clover Health Investments news (Ticker: CLOV), a resource for investors and traders seeking the latest updates and insights on Clover Health Investments stock.

Clover Health Investments, Corp. (NASDAQ: CLOV) is a physician enablement company dedicated to bringing high-quality, affordable healthcare to seniors, particularly those who have historically faced barriers to access. By leveraging its proprietary platform, Clover Assistant, Clover Health empowers physicians to make data-driven, personalized decisions, enhancing patient outcomes while reducing unnecessary costs.

Operating primarily through its Insurance and Non-Insurance segments, Clover Health offers a variety of Medicare Advantage plans, including PPO and HMO options. Through the Insurance segment, Clover Health delivers comprehensive healthcare coverage to members across multiple states. Its Non-Insurance segment participates in the ACO REACH Model, reinforcing its commitment to value-based care.

Clover Assistant aggregates patient data from across the healthcare ecosystem and provides real-time, personalized recommendations at the point of care. This tool has proven effective in improving medication adherence and managing chronic conditions, such as diabetes, high blood pressure, and high cholesterol, ultimately enhancing clinical outcomes.

Recent achievements highlight Clover Health's strategic focus and operational success. The company has demonstrated significant progress in improving medication adherence through the use of Clover Assistant. Additionally, Clover Health is targeting Adjusted EBITDA profitability for the full year of 2024, driven by strong performance in their Medicare plans and strategic investments in technology and care management.

Partnership efforts, such as those with Quartet Health, aim to enhance care delivery for underserved and high-risk patient populations through Clover's home-based care model. This initiative is part of Clover Health's broader strategy to improve health equity and provide comprehensive, coordinated care.

With a steadfast commitment to making care accessible and ensuring patients have the freedom to choose their doctors, Clover Health continues to drive innovation in healthcare. For more information about Clover Assistant, visit Clover Assistant.

Stay updated on the latest developments and strategic moves by Clover Health by following their news updates:

  • Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used (January 8, 2024)
  • Clover Health targeting Adjusted EBITDA profitability for the full-year 2024 (January 10, 2024)
  • Clay Thornton appointed Chief Financial Officer of Medicare Advantage division (March 7, 2024)
  • Partnership with Quartet Health to enhance home-based care delivery (February 5, 2024)
  • Counterpart Assistant now available for external payors and providers (May 29, 2024)
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) has initiated an underwritten public offering of 35 million shares of its Class A Common Stock, with an option for underwriters to purchase an additional 5.25 million shares. The offering aims to raise funds for working capital and general corporate purposes. Citigroup and Deutsche Bank Securities are acting as joint book-running managers. The offering is subject to market conditions, and there are no guarantees regarding its completion or terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.2%
Tags
-
Rhea-AI Summary

Clover Health (NASDAQ: CLOV) announced projected growth of lives under management, expecting a nearly 60% increase to over 200,000 in 2022. The company anticipates its Direct Contracting aligned lives will double to 125,000, following the receipt of an alignment estimate. Clover Health focuses on improving health equity for seniors through innovative Medicare Advantage plans and a proprietary software, the Clover Assistant, designed to enhance clinical decision-making.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.59%
Tags
none
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) has expanded its provider network in Georgia, adding approximately 5,000 primary care physicians and specialists. This growth complements Clover's existing network and provides in-network access to nearly 15,000 providers statewide. The Centers for Medicare and Medicaid Services authorized Clover to operate in 78 additional counties in Georgia starting January 1, 2022, potentially serving over 600,000 new eligible Medicare members. Clover's Medicare Advantage plans will promote cost-sharing parity, allowing members to see their preferred providers regardless of network status.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.65%
Tags
none
Rhea-AI Summary

Clover Health reported Q3 2021 revenue of $427.2 million, up 153% year-over-year driven by increased Medicare lives and a lower Medical Care Ratio (MCR). Lives under management reached 129,100, a 125% increase from last year. The company’s MCR improved by 850 basis points from the previous quarter, now at 102.5%. Clover expects 2022 guidance of 82,000 average Medicare Advantage lives, projecting continued growth. Adjusted operating expenses and losses increased but are expected to stabilize. A 3.5-star rating for its PPO plan highlights performance improvements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.23%
Tags
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) has announced that President Andrew Toy and VP of Investor Relations Derrick Nueman will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on November 10, 2021, at 11:20 a.m. ET. The event aims to highlight Clover's commitment to improving health equity for underserved seniors. A live webcast will be available on Clover's investor relations website, along with an archived replay for 12 months post-event.

Clover targets enhancing healthcare access, particularly focusing on seniors lacking affordable options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
conferences
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) will report its third quarter 2021 financial results on November 8, 2021, after market close. The company aims to improve health equity for underserved seniors in the U.S. A conference call will be held at 5:00 p.m. ET to discuss the financial results and business updates. Investors can access the call by dialing (833) 693-0547 for U.S. callers or (661) 407-1587 for international callers, using the conference ID 4264212. The event will also be available through a webcast on the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) has received an improved Medicare Star Rating of 3.5 stars for its PPO plans, reflecting enhanced access and quality of care for Medicare eligibles. Over 90% of Clover's Medicare Advantage members are enrolled in this PPO plan. The company's 2022 expansion will nearly double its reach to 209 counties across nine states. Notably, around 50% of Clover's members are people of color, surpassing the industry average. Clover aims to address systemic issues in healthcare accessibility, and the rating upgrade emphasizes their commitment to health equity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.08%
Tags
none
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) introduces its 2022 Medicare Advantage plans aimed at providing affordable healthcare to underserved seniors across 209 counties in nine states, including Alabama, Arizona, and Texas. Enrollment begins on October 15 and extends until December 7, 2021, with coverage starting January 1, 2022. The plans offer low out-of-pocket costs, including $0 premiums and copays for primary care visits. Key benefits include over-the-counter allowances, dental, vision, and hearing coverage, affordable insulin prices, and access to telehealth and fitness classes, promoting comprehensive health support.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
none
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) announced a significant expansion, gaining approval from the Centers for Medicare and Medicaid Services (CMS) to operate in 101 new counties starting January 1, 2022. This expansion nearly doubles their geographic footprint to 209 counties across nine states, including their new entry into Alabama. Eligible Medicare beneficiaries can enroll in Clover’s Medicare Advantage plans during the Annual Election Period from October 15 to December 7. This move aims to enhance access to affordable healthcare for underserved communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none

FAQ

What is the current stock price of Clover Health Investments (CLOV)?

The current stock price of Clover Health Investments (CLOV) is $3.23 as of December 20, 2024.

What is the market cap of Clover Health Investments (CLOV)?

The market cap of Clover Health Investments (CLOV) is approximately 1.6B.

What does Clover Health do?

Clover Health is a physician enablement company that focuses on providing affordable, high-quality healthcare for seniors, particularly those on Medicare.

What is Clover Assistant?

Clover Assistant is Clover Health's proprietary software platform designed to aggregate patient data and provide real-time, personalized recommendations to physicians.

How does Clover Health generate revenue?

Clover Health primarily generates revenue through its Insurance segment by offering Medicare Advantage plans. A smaller portion comes from the Non-Insurance segment, which participates in the ACO REACH Model.

What recent achievements has Clover Health made?

Recent achievements include improving medication adherence rates through Clover Assistant and targeting Adjusted EBITDA profitability for the full year of 2024.

What types of Medicare Advantage plans does Clover Health offer?

Clover Health offers both PPO and HMO Medicare Advantage plans.

What is the significance of Clover Health's partnership with Quartet Health?

The partnership aims to enhance care for underserved and high-risk populations through Clover's home-based care model, improving both physical and behavioral health outcomes.

How does Clover Assistant benefit physicians?

Clover Assistant provides real-time, data-driven insights to physicians, aiding in early detection and management of chronic diseases, ultimately improving patient care.

What is the focus of Clover Health's Non-Insurance segment?

The Non-Insurance segment focuses on value-based care models, including participation in the ACO REACH Model.

What are Clover Health's future goals?

Clover Health aims to achieve Adjusted EBITDA profitability for the full year of 2024 and expand the reach of Clover Assistant through its Counterpart Assistant initiative.

How does Clover Health improve healthcare accessibility?

Clover Health is committed to making healthcare accessible by offering affordable Medicare Advantage plans and ensuring patients can choose their preferred doctors.

Clover Health Investments, Corp

Nasdaq:CLOV

CLOV Rankings

CLOV Stock Data

1.59B
388.41M
5.33%
20.16%
3.28%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
FRANKLIN